Numi’s €3M Seed Funding for Cultivated Breast Milk: In an era of remarkable scientific innovation, it’s no surprise that we’re witnessing groundbreaking developments in areas previously thought impossible. Numi, a French milktech startup, formerly known as MUMilk, is pioneering the future of infant nutrition with a vision to recreate in vivo breast milk in vitro through cell cultivation. Today, they have raised an impressive €3 million in Seed funding, signifying a significant step forward in their mission.
Table of Contents: Numi’s €3M Seed Funding for Cultivated Breast Milk
Natural and innovative solution
Founded by Eden Banon-Lagrange and Eugénie Pezé-Heidsieck, Numi is addressing a crucial need for parents and infants alike. Breast milk has long been regarded as the gold standard in infant nutrition due to its unique composition of bioactive molecules that support a child’s growth and development. However, not all parents are able to provide breast milk to their infants for various reasons. This is where Numi steps in, offering a natural and innovative solution.
Numi’s co-founder, Eden Banon-Lagrange, explained
“Thanks to cell culture, we can get as close as possible to the benefits of natural breast milk.” This cutting-edge technology involves isolating human breast cells and cultivating them in controlled laboratory conditions. These cells are sourced through partnerships with hospitals and lactariums, ensuring a safe and ethical supply chain.
The laboratory processes that follow are nothing short of remarkable. The isolated cells are nurtured and coaxed to kickstart milk production. The resulting milk is then carefully extracted and purified to obtain a product that is as close to ‘real’ breast milk as possible, complete with its vital bioactive molecules.
Diverse group of investors
To fund this groundbreaking work, Numi has secured €3 million in Seed funding from a diverse group of investors, including Heartcore Capital, HCVC, Financière Saint James Kima Ventures, and Kost Capital. This financial support is expected to play a pivotal role in Numi’s journey, aiding in recruitment efforts and accelerating their research and development.
Numi is not alone in this exciting field. Bioscience is witnessing a surge in startups dedicated to the advancement of cultivated breast milk. Notable players in the United States include BioMilq, which boasts the backing of none other than Bill Gates. Meanwhile, companies like Helaina and TurtleTree in Singapore are also actively contributing to this transformative industry.
Potential to empower parents
The potential impact of Numi’s work goes far beyond meeting the immediate needs of parents who cannot breastfeed their infants. By providing a viable and ethically sourced alternative to natural breast milk, they are addressing a critical issue in infant nutrition and maternal health. This innovation has the potential to empower parents with choices and ultimately contribute to the well-being of future generations.
As Numi continues to make strides in this remarkable journey, their Seed funding serves as a testament to the confidence that investors and the broader scientific community have in their mission. The future of infant nutrition is looking brighter than ever, thanks to pioneers like Numi, who dare to think beyond the conventional and work tirelessly to bring their vision to life. We look forward to witnessing their progress as they advance the frontiers of science and parenting.
TAGS: Numi’s €3M Seed Funding for Cultivated Breast Milk, Numi’s €3M Seed Funding for Cultivated Breast Milk, Numi’s €3M Seed Funding for Cultivated Breast Milk, Numi’s €3M Seed Funding for Cultivated Breast Milk, Numi’s €3M Seed Funding for Cultivated Breast Milk, Numi’s €3M Seed Funding for Cultivated Breast Milk, Numi’s €3M Seed Funding for Cultivated Breast Milk, Numi’s €3M Seed Funding for Cultivated Breast Milk, Numi’s €3M Seed Funding for Cultivated Breast Milk, Numi’s €3M Seed Funding for Cultivated Breast Milk